Business News • PR NewsWire • Diadem Announces Publication of Clinical Study Confirming Its AlzoSure® Predict Blood Test Can Accurately Predict Progression to Alzheimer's Disease Six Years Before Diagnosis

Diadem Announces Publication of Clinical Study Confirming Its AlzoSure® Predict Blood Test Can Accurately Predict Progression to Alzheimer's Disease Six Years Before Diagnosis

Diadem Announces Publication of Clinical Study Confirming Its AlzoSure® Predict Blood Test Can Accurately Predict Progression to Alzheimer's Disease Six Years Before Diagnosis

—AlzoSure® Predict Uses a Simple Blood Draw to Identify with High Accuracy Whether or Not Individuals Will Progress to Alzheimer's Disease Up to Six Years Before Diagnosis— —Prognostic Performance for Progression to Alzheimer's Significantly Better than PET Amyloid Imaging— —AlzoSure...

View More : https://www.prnewswire.com:443/news-releases/diadem-announces-publication-of-clinical-study-confirming-its-alzosure-pred...

Releted News by prnewswire

Fast Buds launches the most potent autoflowering seeds for 2022

Shionogi & Co., Ltd. and F2G Ltd., Enter Strategic Collaboration to Develop and Commercialize the New Antifungal Agent Olorofim in Europe and Asia

MoEngage Launches a New WhatsApp Business Integration for Enterprises